HomePSTX • NASDAQ
add
Poseida Therapeutics Inc
Previous close
$2.71
Day range
$2.69 - $2.87
Year range
$1.87 - $4.27
Market cap
266.08M USD
Avg Volume
512.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 71.75M | 667.19% |
Operating expense | 10.09M | 24.72% |
Net income | 20.24M | 163.68% |
Net profit margin | 28.20 | 108.30% |
Earnings per share | 0.21 | 160.00% |
EBITDA | 21.06M | 160.56% |
Effective tax rate | 0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 230.85M | -3.34% |
Total assets | 293.58M | -2.87% |
Total liabilities | 206.37M | 15.55% |
Total equity | 87.21M | — |
Shares outstanding | 97.47M | — |
Price to book | 3.01 | — |
Return on assets | 16.67% | — |
Return on capital | 31.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 20.24M | 163.68% |
Cash from operations | -9.59M | -221.63% |
Cash from investing | 27.65M | 158.53% |
Cash from financing | 742.00K | -95.03% |
Net change in cash | 18.80M | 177.00% |
Free cash flow | -10.73M | -199.81% |
About
Founded
2014
Website
Employees
350
